Searched over 200M research papers
10 papers analyzed
These studies suggest 2.5 mg lisinopril is a low dose.
20 papers analyzed
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is commonly prescribed for conditions such as hypertension, heart failure, and certain types of kidney disease. The dosage of lisinopril can vary significantly depending on the condition being treated and the patient's response to the medication.
In studies focusing on male infertility, particularly idiopathic oligospermia, a daily dose of 2.5 mg of lisinopril has been utilized. Research indicates that this dosage can improve seminal parameters, including total sperm count and motility, without causing significant adverse effects . These findings suggest that 2.5 mg is considered a low dose in the context of treating infertility.
In the context of heart failure, the Assessment of Treatment with Lisinopril And Survival (ATLAS) study compared low doses (2.5 to 5 mg daily) with high doses (32.5 to 35 mg daily) of lisinopril. The study found that higher doses were more effective in reducing morbidity and mortality, although low doses were still beneficial and better tolerated by some patients . This indicates that 2.5 mg is on the lower end of the dosing spectrum for heart failure treatment.
For hypertensive children, a study explored the dose-response relationship of lisinopril, with doses ranging from 0.625 mg to 20 mg based on body weight. The study confirmed that even at a low dose of 2.5 mg, lisinopril effectively reduced blood pressure in children, demonstrating its efficacy and safety at lower doses in this population.
In adults with mild to moderate essential hypertension, a study evaluated the antihypertensive effects of various doses of lisinopril. It was found that 2.5 mg produced a measurable but less pronounced effect compared to higher doses (10 mg, 20 mg, and 80 mg), reinforcing the classification of 2.5 mg as a low dose for hypertension management.
Based on the available research, 2.5 mg of lisinopril is generally considered a low dose. This dosage is effective in specific contexts such as male infertility and pediatric hypertension, and it is on the lower end of the dosing spectrum for conditions like heart failure and essential hypertension. The classification of 2.5 mg as a low dose is consistent across various studies, highlighting its role in initial treatment phases or in patients requiring lower medication levels due to tolerance or specific health conditions.
Most relevant research papers on this topic